Warning letter
Collagen Matrix Inc: warning letter of Sep 20, 2016
FDA warning letter 496451 · New Jersey District Office
Key facts
| Reference number | 496451 |
|---|---|
| Company | Collagen Matrix Inc |
| Subject | CGMP/QSR/Medical Devices/Adulterated |
| Issue date | Sep 20, 2016 |
| Posted date | Oct 3, 2016 |
| Issuing office | New Jersey District Office |
| Product type | Devices |
| CFR sections cited | 807.81(a)(3)(i), 820 |
| Inspection city | Allendale |
| Inspection ZIP | 07401 |
| Inspection start date | Nov 9, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: